Evidence map›Paper›PMID 27401861›Full record

ArticleBMC genomics2016

Transcriptomic response of yeast cells to ATX1 deletion under different copper levels.

Ayca Cankorur-Cetinkaya, Serpil Eraslan, Betul Kirdar

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Transcriptomic Analysis of Copper Resistance inAntibiotics (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. NADFrontiers in molecular biosciences · 2021
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Copper Chaperone Atox1 Interacts with Cell Cycle Proteins.Computational and structural biotechnology journal · 2018
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ayca Cankorur-CetinkayaDepartment of Chemical Engineering, Faculty of Engineering, Bogazici University, 34342, Istanbul, Turkey. ayca.cankorur@boun.edu.tr.
Serpil EraslanDepartment of Chemical Engineering, Faculty of Engineering, Bogazici University, 34342, Istanbul, Turkey.
Betul KirdarDepartment of Chemical Engineering, Faculty of Engineering, Bogazici University, 34342, Istanbul, Turkey.
Boğaziçi University · TRKoç University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIron and copper homeostatic pathways are tightly linked since copper is required as a cofactor for high affinity iron transport. Atx1p plays an important role in the intracellular copper transport as a copper chaperone transferring copper from the transporters to Ccc2p for its subsequent insertion into Fet3p, which is required for high affinity iron transport.

resultsIn this study, genome-wide transcriptional landscape of ATX1 deletants grown in media either lacking copper or having excess copper was investigated. ATX1 deletants were allowed to recover full respiratory capacity in the presence of excess copper in growth environment. The present study revealed that iron ion homeostasis was not significantly affected by the absence of ATX1 either at the transcriptional or metabolic levels, suggesting other possible roles for Atx1p in addition to its function as a chaperone in copper-dependent iron absorption. The analysis of the transcriptomic response of atx1∆/atx1∆ and its integration with the genetic interaction network highlighted for the first time, the possible role of ATX1 in cell cycle regulation, likewise its mammalian counterpart ATOX1, which was reported to play an important role in the copper-stimulated proliferation of non-small lung cancer cells.

conclusionsThe present finding revealed the dispensability of Atx1p for the transfer of copper ions to Ccc2p and highlighted its possible role in the cell cycle regulation. The results also showed the potential of Saccharomyces cerevisiae as a model organism in studying the capacity of ATOX1 as a therapeutic target for lung cancer therapy.

Indexed as

Gene DeletionGene Expression Regulation, FungalTranscriptomeCarrier ProteinsCluster AnalysisCopperEpistasis, GeneticFungal ProteinsGene Expression ProfilingGene Regulatory NetworksTranscription, GeneticCarrier ProteinsCopperFungal ProteinsCell cycle regulationCopper chaperonCopper homeostasisCopper transportMenkes diseaseWilson diseaseYeast

Identifiers

PMID27401861
PMCPMC4940881
OpenAlexW2472624160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.